Tag Archives: Collaborative Projects

Plans for Meeting the Dementia Challenge by 2020 (DHSC)

Posted on February 24, 2019 by Dementia and Elderly Care News

Summary The Prime Minister’s Challenge on Dementia 2020 (2015) involved over 50 commitments for making England the best place in the world for dementia care, research and public dementia awareness in general. Feedback was subsequently collected, during 2018, concerning developments … Continue reading →

Collaborative Working Between CCGs and AHSNs: Strategic Commissioning (NHSCC / AHSNs)

Posted on June 1, 2017 by Dementia and Elderly Care News

Summary A briefing from NHS Clinical Commissioners (NHSCC) and Academic Health Science Networks (AHSNs) supplies case studies illustrating the potential benefits of collaborative working between CCGs and AHSNs. A clear focus on specific issues is recommended. Full Text Link Reference … Continue reading →

Posted in Charitable Bodies, Commissioning, Community Care, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Integrated Care, Management of Condition, National, NHS, Non-Pharmacological Treatments, Quick Insights, UK, Universal Interest | Tagged Academic Health Science Network (AHSN) for South London, Academic Health Science Network for the North East and North Cumbria (AHSN NENC), Academic Health Science Networks (AHSNs), AHSN Network, Building Research Partnerships, Care Partnerships, CCGs: Clinical Commissioning Groups, Clinical Commissioning Groups (CCGs), Collaboration, Collaboration for Coordinated Care, Collaborative Commissioning, Collaborative Projects, Collaborative Research, Collaborative Working, Collaborative Working in Local Communities, Collaborative Working in Local Communities for Benefit of Patients, DOACs, East Lancashire CCG, East Midlands AHSN, East Midlands CCGs, Health Innovation Network (South London AHSN), Healthier You: NHS Diabetes Prevention Programme, Imperial College Health Partners, Kent CCGs, Kent Surrey and Sussex AHSN, Kent Surrey Sussex AHSN, Local AHSNs, Local Strategic Commissioning, London Borough of Newham, London CCGs, Low Cost Care Coordination, Neurorehabilitation Pathways, Newham CCG, NHS Clinical Commissioners, NHS Clinical Commissioners (NHSCC), NHS Diabetes Prevention Programme, NHS Diabetes Prevention Programme (NHS DPP), NHS England AHSN Network, NHS Newcastle Gateshead CCG, NHSCC: NHS Clinical Commissioners, North East and North Cumbria AHSN, North West Coast Innovation Agency, North West Coastal AHSN, North West London CCGs, Nottingham Biomedical Research Centre, Partnership Working, Population Health Improvement, Reducing A&E Admissions, Reducing Strokes Due to Atrial Fibrillation, Research Into Practice, Scarred Liver Project, Somerset CCG, South West AHSN, Strategic Commissioning, Sustainability and Transformation Partnerships, System-Wide Learning and Collaboration, UCLPartners, Unplanned Hospital Admissions, Wessex AHSN | Leave a comment

NICE Participation in European ROADMAP Project: Faster Access to Alzheimer’s Disease Drugs? (NICE)

Posted on January 12, 2017 by Dementia and Elderly Care News

Summary NICE is participating in the ROADMAP initiative, which is working on a sustainable platform for “real world” evidence generation concerning Alzheimer’s Disease and (hopefully) faster development of disease-modifying drugs. “The IMI (Innovative Medicines Initiative) is Europe’s largest public-private partnership, … Continue reading →

Posted in Commissioning, For Researchers (mostly), In the News, International, National, Quick Insights, UK, Universal Interest | Tagged Academia-Industry Partnerships, Big Data, Big Data for Better Outcomes Programme (IMI), Big Data Funding and Research, Collaborative Projects, Cross-Sector Partnerships, Data Sharing, Dementia Research, Disease Modification, Disease Modifying Treatment by 2025 (Aim), Disease-Modifying Treatments for Dementia, Dr Matthew Norton: Alzheimer's Research UK, Electronic Health Records (EHRs), European ROADMAP Project, Global Leadership, Global Outlook, IMI (Innovative Medicines Initiative), IMI’s Big Data for Better Outcomes Programme, Innovative Medicines Initiative (IMI), International Collaborations, International Programmes, Leveraging Big Data, National Institute for Health and Care Excellence (NICE), Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, NICE’s Science Policy and Research Programme, Pan-European Collaborations, Partnership, Partnership and Collaboration, Partnership Working, Prof Carole Longson: National Institute for Health and Care Excellence (NICE), Professor Carole Longson: Director of Centre for Health Technology Evaluation at NICE, Professor John Gallacher: University of Oxford, Promisary Science, Publicly-Funded UK Big Data Research, Research and Innovation, Resource and Incentives, ROADMAP Initiative | Leave a comment

New Drugs for Dementia (POST Note PN 535)

Posted on August 29, 2016 by Dementia and Elderly Care News

Summary The Parliamentary Office of Science and Technology (POST) has produced a briefing outlining some of the challenges in developing new drugs for dementia, explained in the context of ongoing UK and international research programmes. There is an extensive bibliography, … Continue reading →

Posted in Alzheimer's Society, Alzheimer’s Research UK, Antipsychotics, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Models of Dementia Care, National, Pharmacological Treatments, Quick Insights, Statistics, UK, Universal Interest | Tagged Academic Institutes in the UK, Academy of Social Sciences, Aducanumab (Biogen), Alzheimer’s Association, Alzheimer’s Research UK’s Drug Discovery Alliance, Behavioural and Psychological Symptoms of Dementia (BPSD), Big Data, Big Data Funding and Research, Big Pharma, Biomarkers, Biomarkers Predicting Cognitive Decline and Alzheimer's Disease, BPSD: Behavioral and Psychological Symptoms of Dementia, British Psychological Society (BPS), Co-ordination and Data Analytics, Cognitive Health in Ageing Register for Investigations, Collaborative Projects, Collaborative Research, Dementia Consortium, Dementia Risk Prevention, Dementias Platform UK, Dementias Platform UK (DPUK), Dementias Platform UK: MRC, Disease Modifying Treatment by 2025 (Aim), Disease-Modifying Therapies, Disease-Modifying Therapies for Dementia, Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU), DPUK: Dementias Platform UK, Drug Discovery Alliance, Drug Licensing Approval, Drugs for BPSD, Drugs for Cognitive Symptoms of Cognitive Decline and Dementia, EAMS: Early Access to Medicines Scheme, Early Access to Medicines Scheme, Effective Non-Drug Interventions, Etanercept, European Prevention of Alzheimer's Dementia Consortium (EPAD), European Prevention of Alzheimer’s Dementia Consortium, Identification of People At Risk of Dementia, International Collaborations, International Programmes, International Research, Join Dementia Research, Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neurodegenerative Disorders, Neurodegenerative Research, New Drugs for Dementia (POST Note PN 535), NIHR Clinical Research Network, Observations & Trials in Dementia Research, Parliament, Parliamentary Office of Science & Technology, Parliamentary Office of Science & Technology (POST), Participation in Research, Patient Access to New Drugs, Pharmaceutical Industry, Pioglitazone, POST: Parliamentary Office of Science & Technology, Pre-Symptomatic Diagnosis of Dementia, Preclinical Biomarkers and Dementia, Preclinical Indicators and Dementia, Prevention, Public Participation in Research, Research and Development, Research and Innovation, Research Commitment, Research Culture, Research Mapping, Research Networks, Solanezumab (Eli Lilly), Symptom-Modifying Drugs for Dementia, UK Dementia Research Institute, UK Parliament, UK Patient Recruitment Initiatives, Verubecestat (Merck), Well-Being and Health for People With Dementia (WHELD) Program | Leave a comment

Two Further Improvements: Dementia Services Seven Days a Week / Dementia Awareness for People Aged Over Forty (BBC News / Department of Health)

Posted on March 14, 2016 by Dementia and Elderly Care News

Summary Two further aspects of the latest implementation plans for the Prime Minister’s Challenge on Dementia 2020 were emphasised a week ago. Seven day NHS services are planned to benefit dementia patients, with more frequent patient assessments and better care … Continue reading →

Who and What is the Dementia Envoy? (WDC / Department of Health)

Posted on March 8, 2016 by Dementia and Elderly Care News

Summary The Prime Minister has appointed David Mayhew as the latest Dementia Envoy. Dennis Gillings was the former World Dementia Envoy. “The envoy works with countries, corporations and leaders from around the world, sharing expertise and promoting research and support … Continue reading →

Posted in Alzheimer’s Research UK, Charitable Bodies, Commissioning, Department of Health, For Researchers (mostly), In the News, International, Mental Health, Models of Dementia Care, National, Non-Pharmacological Treatments, Pharmacological Treatments, Quick Insights, UK, Universal Interest | Tagged Academia-Industry Partnerships, Alzheimer’s Research UK (ARUK), British Prime Minister's Office, Challenge on Dementia (David Cameron), Collaborative Projects, Cross-Sector Partnerships, Data Sharing, David Cameron, David Mayhew CBE: Former Chairman of JP Morgan Cazenove, David Mayhew CBE: Vice Chairman of JP Morgan’s Global Investment Bank, David Mayhew CBE: Wellcome Trust Investment Committee, David Mayhew: Chairman of Alzheimer’s Research UK, David Mayhew: Dementia Envoy (2016-), Dementia Challenge, Dementia Consortium, Dementia Discovery Fund, Dementia Discovery Fund (DDF), Dementia Friends, Dementia Innovation, Dementia Research, Dementia Research Funding, Dementia Research Priorities, Dementia Research: UK Impact, Dennis Gillings: Former World Dementia Envoy, Department of Health Dementia Challenge, GAAD: Global Action Against Dementia, Global Action Against Dementia, Global Action Against Dementia (GAAD), Global Envoy for Dementia Innovation, Global Outlook, Global Social Investment for Dementia, Government Research Funding, International Collaborations, International Programmes, JP Morgan, Knowledge Translation, Leadership, Partnership, Partnership and Collaboration, Partnership Working, Prime Minister's Challenge on Dementia, Prime Minister's Office, Prime Minister’s Dementia Challenge, Research and Innovation, Rt Hon Jeremy Hunt MP: Former Secretary of State for Health, WDC: World Dementia Council, World Alzheimer Report 2014, World Dementia Council, World Dementia Envoy | Leave a comment

Latest Challenge on Dementia 2020 Implementation Plan (BBC News / Department of Health)

Posted on March 7, 2016 by Dementia and Elderly Care News

Summary The Prime Minister’s Challenge on Dementia 2020 contained over 50 commitments towards making England the best place in the world for dementia care, research and societal dementia awareness by 2020. The Department of Health’s updated implementation plan specifies how … Continue reading →

Posted in Acute Hospitals, Alzheimer's Society, Alzheimer’s Research UK, BBC News, Charitable Bodies, Commissioning, Community Care, Department of Health, Diagnosis, End of Life Care, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), In the News, Integrated Care, Management of Condition, Mental Health, Models of Dementia Care, National, NHS, NHS England, Non-Pharmacological Treatments, Patient Care Pathway, Person-Centred Care, Personalisation, Quick Insights, Standards, UK, Universal Interest | Tagged Achieving Dementia Friendly Acute care, Ageing and Dementia, Ageing and Society, Ageing Policy in the UK, Ageing Population, Alistair Burns: NHS England’s National Clinical Director for Dementia, Alzheimer's Association, Alzheimer’s Research UK (ARUK), Alzheimer’s Society Connecting Communities Project, Awareness and Understanding, Awareness Campaigns, BBC Health News, Behavioural Risk Factors, Behavioural Risk Factors and Dementia, Better Care Fund, Black Asian and Minority Ethnic (BAME), Black Asian and Minority Ethnic Communities (UK), British Prime Minister's Office, Building Dementia Friendly Communities, Burden of Dementia, Care and Compassion, Care at Home, Carer Support, Carer Support Services, CCG Improvement and Assessment Framework (CCGIAF), Challenge on Dementia (David Cameron), Challenge on Dementia 2020, Challenge on Dementia 2020 Implementation Plan, Citizen Participation, Collaboration, Collaborative Projects, Collaborative Research, Collaborative Working, Commitment to Carers (NHS England), Community Participation, Compassionate Care, Connecting Communities, Connecting Communities Initiative, Creating Dementia Friendly Environments, Creating Dementia Friendly Hospitals, Cross-Sector Partnerships, David Cameron, DEEP2: Dementia Engagement and Empowerment Project, Dementia 2020 Citizens’ Panel, Dementia Action Alliance (DAA), Dementia Advisers, Dementia Advisor, Dementia Advisor Service, Dementia Awareness, Dementia Awareness Training, Dementia Challenge, Dementia Consortium, Dementia Friendly Charters, Dementia Friends, Dementia Friends Campaign, Dementia Friends Champions, Dementia Friends Programme, Dementia Health and Care Champion Group, Dementia Intelligence Network (DIN), Dementia Profile Tool, Dementia Programme Board, Dementia Research, Dementia Research Institute, Dementia Risk Factors, Dementia State of the Nation, Dementia UK, Dementia Voice, Dementia-Friendly Businesses, Dementia-Friendly Care Homes, Dementia-Friendly Cities, Dementia-Friendly Communities, Dementia-Friendly Employers, Dementia-Friendly Hospitals, Dementia-Friendly Housing, Dementia-Friendly Neighbourhoods, Dementia-Friendly Sectors, Dementia-Friendly Towns, Dementias Platform UK, Dementias Platform UK (DPUK), Department of Health Dementia Challenge, Department of Health Dementia Challenge (2020), Dignity in Care, Dignity in Dementia, Disease Modifying Treatment by 2025 (Aim), Disease-Modifying Therapies, Disease-Modifying Therapies for Dementia, DPUK: Dementias Platform UK, Elderly Human Rights, Global Action Against Dementia, Global Burden of Dementia, Global Clinical Trials Fund (GCTF), Global Fund on Dementia, Global Leadership, Global Outlook, Healthy Behaviours, Healthy Communities, Healthy Lifestyles, Improving Care for People with Dementia, Inappropriate Prescribing, Inappropriate Use of Antipsychotics in Dementia, Integration of Health and Care, International Collaborations, International Dementia Research Inventories, International Programmes, Involvement and Participation, Jane Ellison, Join Dementia Research, Join Dementia Research: Recruitment Onto Dementia Studies, Joint Action on Dementia, Lifestyle Risk Factors, Local Dementia Action Alliances, Local Dementia Action Alliances in England, Local Government, Local Health and Care Economies, Local Health and Care Services, Local Health and Wellbeing Boards, Loneliness and Dementia, Loneliness and Social Isolation, Maintaining Independence, NHS England CCG Improvement and Assessment Framework, NHS England's Five Year Forward View (2014), NHS England’s Commitment to Carers, NHS Five Year Forward View (5YFV), NHS Health Check, NHS Health Check Programme, Organisation for Economic Co-operation and Development (OECD), Participation in Research, Participation in Research Studies, Partnership and Collaboration, Partnership Working, Patient and Public Participation, Prime Minister's Challenge on Dementia, Prime Minister's Office, Prime Minister’s Challenge On Dementia 2020, Prime Minister’s Dementia Challenge, Professor Alistair Burns, Public Health England (PHE), Public Health England Dementia Intelligence Network, Public Participation in Research, Reducing Inappropriate Use of Antipsychotics in Dementia, Reducing Stigma, Referrals, Research and Innovation, Risk Factors, Risk Factors for Alzheimer's Diseease, Risk Management, Shared Delivery Plan for Health and Social Care, Support for Carers, Sustainable Care, Sustainable Health and Care Services, Tackling Barriers to Innovation, Tide Network, Unhealthy Behaviours, Unhealthy Lifestyles, Unhealthy Living, World Dementia Council, World Dementia Envoy, World Health Organization (WHO) | Leave a comment

Significant Changes at the World Dementia Council? (WDC)

Posted on February 28, 2016 by Dementia and Elderly Care News

Summary There has been reform within the World Dementia Council (WDC). The changes are intended to make this body “more representative” in global terms (if such were possible) and fully independent. The Council now includes a wider range of international … Continue reading →

Posted in Alzheimer’s Disease International (ADI), Alzheimer’s Research UK, Charitable Bodies, Commissioning, Department of Health, Diagnosis, For Researchers (mostly), In the News, International, Management of Condition, Mental Health, Models of Dementia Care, Non-Pharmacological Treatments, Person-Centred Care, Pharmacological Treatments, Quick Insights, UK, Universal Interest, World Health Organization (WHO) | Tagged Abuse of Vulnerable Adults, Academia-Industry Partnerships, Academic Research, Alternatives to Antipsychotic Drugs, Alzheimer's Association, Alzheimer’s Disease: Risk Factors, Alzheimer’s Research UK (ARUK), Argentina, ARUK: Alzheimer’s Research UK, Assistive Technology, Associate Members (WDC), Awareness, Awareness Raising, Behavioural Risk Factors, Big Data, Big Data Partnership, Big Pharma, Bill and Melinda Gates Foundation, Biopharmaceutical Companies, Biotechnology, Challenge on Dementia (David Cameron), Charitable Funding, Clinical Trial Efficiencies, Collaboration, Collaborative Projects, Cross-Sector Partnerships, Data Sharing, Dementia Challenge, Dementia Consortium, Dementia Discovery Fund, Dementia Discovery Fund (DDF), Dementia Friends, Dementia Research, Dementia Research Funding, Dementia Research Priorities, Dementia Research: UK Impact, Dementia Risk Factors, Dementia Risk Prevention, Dementia Risk Reduction, Dementia Risk Reduction and Prevention, Dennis Gillings: Former World Dementia Envoy, Department of Health Dementia Challenge, Department of Health’s Integrated Development Initiative, Digital Technology, Disease Modifying Treatment by 2025 (Aim), Disease-Modifying Therapies, Disease-Modifying Therapies for Dementia, Dr Yves Joanette: Scientific Director of Canadian Institute of Health Research (Institute of Aging), Emerging Technology, Enabling Technology, Future Long-Term Care Costs, GAAD: Global Action Against Dementia, Global Action Against Dementia, Global Action Against Dementia (GAAD), Global Outlook, Global Social Investment for Dementia, Government Research Funding, Hilary Doxford: World Dementia Council Member, Indonesia, Information Technology, Innovative Technology, International Collaborations, International Dementia Research Inventories, International Programmes, Interventions for Social Isolation and Loneliness in Men, Investment in Technology, Join Dementia Research, Leveraging Big Data, Lifestyle Risk Factors, Loneliness and Social Isolation, Modifiable Risk Factors, National Institute of Ageing (NIA), Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neurodegenerative Disorders, Neurological Research, Nigeria, Open Data and Big Data, Organisation for Economic Co-operation and Development (OECD), Partnership and Collaboration, Partnership Working, Philanthropic Funding, Pipeline Databases, Prevention, Prevention of Dementia, Prime Minister’s Challenge On Dementia 2020, Raj Long: Senior Regulatory Officer for Integrated Development in Global Health at the Bill & Melinda Gates Foundation, Raj Long: Vice Chair of World Dementia Council, Reducing Antipsychotic Prescriptions in Dementia, Reducing Inappropriate Use of Antipsychotics in Dementia, Reducing Stigma, Regulatory Agencies, Regulatory Experts, Research and Development, Research and Innovation, Research Commitment, Research Funding, Resource and Incentives, Restraint and Restrictions, Restraint in Health and Adult Social Care, Risk Factors, Risk Reduction, Risk Reduction (Formerly Termed Prevention by WDC), Rt Hon Jeremy Hunt MP: Former Secretary of State for Health, Social Isolation, Stigma, Taiwan, Treatment and Prevention of Dementia, US National Institute on Aging, WDC: World Dementia Council, World Dementia Council, World Health Organisation (WHO), Yves Joanette: Chair of World Dementia Council | Leave a comment

Government Commitment to the Global Action Against Dementia (WDC / Department of Health)

Posted on November 25, 2015 by Dementia and Elderly Care News

Summary The Department of Health has responded to Raj Long’s Finding a path for a cure for dementia: an independent report into an integrated approach to dementia drug development report, with a Strategy Report and an open letter. There is … Continue reading →

Posted in Alzheimer's Society, Alzheimer’s Research UK, Charitable Bodies, Commissioning, Department of Health, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, Integrated Care, International, Management of Condition, Mental Health, Models of Dementia Care, National, Pharmacological Treatments, Quick Insights, UK, Universal Interest, World Health Organization (WHO) | Tagged $100m Dementia Discovery Fund, Academia-Industry Partnerships, Academic Research, Accelerated Access Review, AIFA: Italian Medicines Agency, Alzheimer's Association, Alzheimer’s Research UK (ARUK), ARUK: Alzheimer’s Research UK, Attrition Analysis, BfArM: Federal Institute of Drugs and Medical Devices, Bill and Melinda Gates Foundation, Biopharmaceutical Companies, CEOi: Global CEO Initiative on Alzheimer’s Disease, Challenge on Dementia (David Cameron), Charitable Funding, Clinical Trial Efficiencies, Collaboration, Collaborative Projects, Commission Expert Group on Safe and Timely Access to Medicines for Patients (STAMP), Composite End Points, Continuity Plans (WDC and GAAD Agenda), Council for International Organizations of Medical Sciences (CIOMS), Cross-Sector Partnerships, Danish Health and Medicines Authority, Data Sharing, Dementia Challenge, Dementia Consortium, Dementia Discovery Fund, Dementia Discovery Fund (DDF), Dementia Integrated Development Initiative, Dementia Research, Dementia Research Funding, Dementia Research Priorities, Dementia Research: UK Impact, Department of Health Dementia Challenge, Department of Health’s Integrated Development Initiative, Disease Modifying Treatment by 2025 (Aim), Disease-Modifying Therapies, Disease-Modifying Therapies for Dementia, DKMA: Danish Health and Medicines Authority, EMA: European Medicines Agency, EU Joint Programme on Neurodegenerative Disease Research (JPND), EU’s Neurodegenerative Disease Research Joint Programme (JPND), European Medicines Agency, European Medicines Agency (EMA), European Prevention of Alzheimer's Dementia Consortium (EPAD), First Global Ministerial Conference on Global Action Against Dementia, Foundation Plan Alzheimer’s, GAAD: Global Action Against Dementia, George Freeman MP: Former Life Sciences Minister, Gill Ayling: Deputy Director of Global Action Against Dementia (Department of Health), Global Action Against Dementia, Global Action Against Dementia (GAAD), Global Alzheimer’s Leadership Series (GoALS), Global Alzheimer’s Platform, Global CEO initiative (CEOi) on Alzheimer’s Disease, Global Leadership, Global Ministerial Conference on Global Action Against Dementia (WHO), Global Observatory on Dementia (WHO), Global Outlook, Global Social Investment for Dementia, Government Research Funding, Integrated Development Advisory Group, International Coalition of Medicines Regulatory Agencies, International Collaborations, International Dementia Advisory Platform (IDAP), International Dementia Research Inventories, International Pharmaceutical Regulatory Forum, International Programmes, Italian Medicines Agency, Jane Ellison MP: Parliamentary Under Secretary for Public Health, Joint Programme on Neurodegenerative Disease Research (JPND), JPND: Joint Programme on Neurodegenerative Disease Research, Medical Research Council (MRC), Modelling and Extrapolation, Multilateral Cooperation, National Institute for Health Research (NIHR), National Institute of Ageing (NIA), Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neurodegenerative Disorders, Neurological Research, NeuroMap, New York Academy of Sciences (NYAS), Observatory on Dementia (WHO), OLS Accelerated Access Review, Organisation for Economic Co-operation and Development (OECD), Partnership and Collaboration, Partnership Working, Philanthropic Funding, Pipeline Databases, Prime Minister’s Challenge On Dementia 2020, Raj Long: Senior Regulatory Officer for Integrated Development in Global Health at the Bill & Melinda Gates Foundation, Regulatory Agencies, Regulatory Experts, Research and Development, Research and Innovation, Research Commitment, Research Funding, Resource and Incentives, Risk Benefit Balance, Swiss Medic, University of Newcastle, US National Institute on Aging, WDC: World Dementia Council, WHO Observatory on Dementia, WHO's Global Observatory on Dementia, World Dementia Council, World Health Organisation (WHO) | Leave a comment

Dementia Discovery Fund Launched (WDC / ARUK)

Posted on November 18, 2015 by Dementia and Elderly Care News

Summary The Dementia Discovery Fund (DDF) was launched on October 21st 2015. Full Text Link Reference Launch of Dementia Discovery Fund. London [Online]: World Dementia Council (WDC), November 10th 2015. See also: Full Text Link Reference $100m Dementia Discovery Fund … Continue reading →

Posted in Alzheimer’s Research UK, Charitable Bodies, Commissioning, Department of Health, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, Management of Condition, Mental Health, Models of Dementia Care, National, Pharmacological Treatments, Quick Insights, UK, Universal Interest | Tagged $100m Dementia Discovery Fund, Ageing and Dementia, Ageing and Society, Ageing Population, Alzheimer's Research UK, Alzheimer’s Research UK (ARUK), Andrew Plump: Chief Medical and Scientific Officer at Takeda Pharmaceutical Company Limited, ARUK: Alzheimer’s Research UK, Big Pharma, Biogen, Biopharmaceutical Companies, Collaboration, Collaborative Projects, Cross-Sector Partnerships, Dementia Discovery Fund, Dementia Discovery Fund (DDF), Dementia Research, Dementia Research Funding, Disease Modifying Treatment by 2025 (Aim), Disease-Modifying Therapies, Disease-Modifying Therapies for Dementia, Dr Jan Lundberg: President of Lilly Research Laboratories, Dr Matthew Norton: Alzheimer's Research UK, Drug Discovery Programmes, Drug Identification, Drug Regulation, Drug-Development Pipeline, Eli Lilly Inc., Eli Lilly’s UK Dementia Research Centre, First Global Ministerial Conference on Global Action Against Dementia, First WHO Ministerial Conference on Global Action Against Dementia, G8 Dementia Summit: Global Action Against Dementia, GlaxoSmithKline, Global Action Against Dementia, Global Action Against Dementia (GAAD), Global Ministerial Conference on Global Action Against Dementia (WHO), Global Outlook, Government Research Funding, GSK Johnson & Johnson, International Collaborations, International Programmes, Jane Ellison, Johnson & Johnson, Lilly, Mikael Dolsten: President of Worldwide Research and Development at Pfizer, Partnership, Partnership and Collaboration, Partnership Working, Patrick Vallance: President of Pharmaceuticals R&D at GSK, Paul Stoffels: Worldwide Chairman of Johnson & Johnson, Pfizer, Pfizer Inc., Pharmaceutical Industry, Research and Development, Research and Innovation, Research Commitment, Research Funding, SV Life Sciences, SV Life Sciences (SVLS), Takeda, WDC: World Dementia Council, World Dementia Council | Leave a comment

Tag Archives: Collaborative Projects

Dementia Discovery Fund Launched (WDC / ARUK)

Recent Posts

Archives

Categories

Google Translate (100+ Languages)

Recommended Sites